Tevogen Bio has expanded its partnership with Microsoft, aiming to further its AI-centred collaboration and advance its ...

Fortress Biotech (FBIO) and its majority-owned subsidiary, Helocyte, announced that the first patient was dosed in a multicenter, ...

Maite Rodriguez and her husband gave their 6-year-old daughter with sickle cell disease a lifeline when they conceived a ...

Ocular inflammation and vision-threatening adverse events to cancer therapies can be mitigated once researchers understand their mechanisms.

Despite progress in healthcare services for individuals living with sickle cell disease (SCD) in Africa, substantial gaps ...

In this article, Momin Shah discusses how to ensure that NGS protocols are optimized from the outset to save time and costs ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Tevogen Bio’s expanding collaboration with Microsoft represents a bold step forward, combining the best of biotech and cutting-edge technology. The partnership could accelerate the development of new ...